GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke.
about
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderA new look at an old drug: neuroprotective effects and therapeutic potentials of lithium saltsPotential therapeutic effects of neurotrophins for acute and chronic neurological diseasesROS and brain diseases: the good, the bad, and the uglyWnt your brain be inflamed? Yes, it Wnt!Glaucoma: the retina and beyondPossible role of the glycogen synthase kinase-3 signaling pathway in trimethyltin-induced hippocampal neurodegeneration in miceBeneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models.Novel osmotin attenuates glutamate-induced synaptic dysfunction and neurodegeneration via the JNK/PI3K/Akt pathway in postnatal rat brainA new avenue for lithium: intervention in traumatic brain injury.Telmisartan protects central neurons against nutrient deprivation-induced apoptosis in vitro through activation of PPARγ and the Akt/GSK-3β pathway.Therapeutic benefits of delayed lithium administration in the neonatal rat after cerebral hypoxia-ischemia.Proline-, glutamic acid-, and leucine-rich protein 1 mediates estrogen rapid signaling and neuroprotection in the brainIdentification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, that Prolongs the Median Survival Time of Δ7 SMA KO Mouse Model of Spinal Muscular Atrophy.Attenuation of Cerebral Ischemic Injury in Smad1 Deficient Mice.Inhibition of glycogen synthase kinase-3β enhances cognitive recovery after stroke: the role of TAK1.Enhanced Chondrogenic Differentiation of Human Umbilical Cord Wharton's Jelly Derived Mesenchymal Stem Cells by GSK-3 Inhibitors.The Neuroprotective Effect of Lithium in cannabinoid Dependence is Mediated through Modulation of Cyclic AMP, ERK1/2 and GSK-3β Phosphorylation in Cerebellar Granular Neurons of RatGlycogen synthase kinase-3 levels and phosphorylation undergo large fluctuations in mouse brain during development.Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres.Lithium to the Rescue.Temporal Expression of Apelin/Apelin Receptor in Ischemic Stroke and its Therapeutic Potential.Novel actions of progesterone: what we know today and what will be the scenario in the future?Wnt and lithium: a common destiny in the therapy of nervous system pathologies?Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseasesDock3 attenuates neural cell death due to NMDA neurotoxicity and oxidative stress in a mouse model of normal tension glaucoma.PELP1 - A Key Mediator of Estrogen Signaling and Actions in the Brain.Lithium-induced neuroprotection in stroke involves increased miR-124 expression, reduced RE1-silencing transcription factor abundance and decreased protein deubiquitination by GSK3β inhibition-independent pathways.Overactivation of NR2B-containing NMDA receptors through entorhinal-hippocampal connection initiates accumulation of hyperphosphorylated tau in rat hippocampus after transient middle cerebral artery occlusion.A reduced risk of stroke with lithium exposure in bipolar disorder: a population-based retrospective cohort study.Dysfunction of Microglial STAT3 Alleviates Depressive Behavior via Neuron-Microglia Interactions.GSK-3β inhibition protects mesothelial cells during experimental peritoneal dialysis through upregulation of the heat shock response.Neurological functions of the masterswitch protein kinase - gsk-3.Omentin-1 effects on mesenchymal stem cells: proliferation, apoptosis, and angiogenesis in vitro.GSK3β negatively regulates TRAX, a scaffold protein implicated in mental disorders, for NHEJ-mediated DNA repair in neurons.Inositol depletion, GSK3 inhibition and bipolar disorder.4-Phenylbutyric Acid (4-PBA) and Lithium Cooperatively Attenuate Cell Death during Oxygen-Glucose Deprivation (OGD) and Reoxygenation.GSK3β Controls mTOR and Prosurvival Signaling in Neurons.Delayed treatment of 6-Bromoindirubin-3'-oxime stimulates neurogenesis and functional recovery after focal ischemic stroke in mice.Intranasal delivery of bone marrow mesenchymal stem cells improved neurovascular regeneration and rescued neuropsychiatric deficits after neonatal stroke in rats.
P2860
Q24626017-0E3CD481-BC8A-45BD-BC2C-F1EB666C39E6Q26741164-FF7229F8-5C2E-439A-98D0-E207B5C91D2FQ26827281-9FFCB2DB-6D5F-4B0C-A6E5-028E0680E8BFQ27014070-BD00387E-FE7E-4F00-B83D-E4424FA0E4BAQ27022507-3AD990C1-D3CA-4D83-A4E5-8355A7652AE5Q28077518-64CA19BA-777A-4CD0-A564-B4D9CB7434D6Q28535092-40592987-CCB6-4DB1-91BB-121F71F4B949Q33566724-B879DC92-351D-4DCA-85F7-3A3A042E5909Q33694968-006F723C-6271-415A-9CA9-EF23E3531F1BQ33777980-A3EF6316-112A-4D0E-86F4-A5879B08046DQ33861931-5F9EFB67-7514-4939-BF2A-B76B8C530345Q34166139-99A088E5-7BC8-47F6-B1D2-6F992809AEB3Q34503754-2BD7EC16-010B-45DF-A179-2BA81109B621Q35758331-3BB599B6-ADAA-4610-93D0-902CB930ADB1Q35758451-A139D394-221D-4F48-8923-1CDFF1796A88Q35773229-5A3B26BE-1F9A-410B-8985-61123A95E57CQ36242570-4A14CF5A-FFC3-43E3-89DC-FB9689888566Q36358395-59F9CF72-7AD6-4C3D-87DB-BC1896D426B9Q36419565-04232A45-1D3F-4FDB-8323-20ECF25BB6F2Q36894284-46DBF24D-CB10-4F76-96F6-92F33610B16FQ37078843-1C2CC3E5-A4AC-44D1-911B-E979CF2EA6C1Q37597877-44F68619-B088-4FDB-9B93-0B8118A206B2Q38024835-722DF724-E596-4296-9933-B89186DD2726Q38113139-CE54CEF1-BC6C-4255-B3C1-5947237000A9Q38272835-296F9253-7EDD-4614-A49F-897B11FC7987Q39126093-8CF9FB0D-DC4F-4452-9F02-7441C2317FF3Q39293057-BC6F1C5F-FD1C-4D0A-A9C1-7DBFA55714F0Q39812275-F2D49439-811E-400A-9822-C4224898615DQ41026712-48469DCC-80B9-466E-A032-5948F8B232ABQ41334184-815B7958-51C5-4E8B-AF87-1152BE248C62Q41449300-F36CAB92-C10A-48F9-80E5-F584091713F6Q42085317-7FF6D798-1BF4-43B0-8EB6-F97B6A9D4645Q42195030-E20D41E7-F2E7-4A5C-90ED-7AE752D3C800Q42373535-91782B38-D847-44E2-9768-A76007018F55Q47234216-62DC1C4F-3449-41D4-8164-954F27A62CD0Q48056810-05203C60-94E2-45A8-8444-59C7563EA81DQ48278176-2C40264C-7210-4486-9B60-DBFFA53342D9Q48295081-5020E6F0-830C-40B4-B8CA-FA6CAD11830DQ48345489-012E9735-A458-49B0-A428-1E6160F5D9ADQ48346065-6BD56791-238A-4533-8F1B-29A5F3D13478
P2860
GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
GSK-3 as a Target for Lithium- ...... mal Models of Ischemic Stroke.
@ast
GSK-3 as a Target for Lithium- ...... mal Models of Ischemic Stroke.
@en
type
label
GSK-3 as a Target for Lithium- ...... mal Models of Ischemic Stroke.
@ast
GSK-3 as a Target for Lithium- ...... mal Models of Ischemic Stroke.
@en
prefLabel
GSK-3 as a Target for Lithium- ...... mal Models of Ischemic Stroke.
@ast
GSK-3 as a Target for Lithium- ...... mal Models of Ischemic Stroke.
@en
P2093
P2860
P356
P1476
GSK-3 as a Target for Lithium- ...... mal Models of Ischemic Stroke.
@en
P2093
Chi-Tso Chiu
De-Maw Chuang
Zhifei Wang
P2860
P356
10.3389/FNMOL.2011.00015
P577
2011-08-09T00:00:00Z